ID

34332

Descripción

Safety and Efficacy of Oncoxin in Hepatocellular Carcinoma (HCC); ODM derived from: https://clinicaltrials.gov/show/NCT01392131

Link

https://clinicaltrials.gov/show/NCT01392131

Palabras clave

Versiones (2)
  1. 16/1/19 16/1/19 -
  2. 14/5/19 14/5/19 -
Titular de derechos de autor

see on clinicaltrials.gov

Subido en

16 de enero de 2019

DOI

Para solicitar uno, por favor iniciar sesión.

Licencia

Creative Commons BY-NC 3.0
Comentarios del modelo :

Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.

Volver a los comentarios del modelo
Comentarios de grupo de elementos para :

Comentarios del elemento para :

Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.

Eligibility Hepatocellular Carcinoma NCT01392131

Inglés

Eligibility Hepatocellular Carcinoma NCT01392131

1 formularios  
Inclusion Criteria
Descripción

Inclusion Criteria

Alias
UMLS CUI
C1512693
patients with hcc irrespective of etiology, age, gender and status of underlying liver disease.
Descripción

ID.1

Tipo de datos

boolean

patients with hcc who are not suitable candidates for established modalities of treatment i.e. surgery and/or chemotherapy.
Descripción

ID.2

Tipo de datos

boolean

patients with hcc who have evidence of tumor metastasis
Descripción

ID.3

Tipo de datos

boolean

patients with hcc who are voluntarily unwilling to take established modalities of treatment i.e. surgery and/or chemotherapy.
Descripción

ID.4

Tipo de datos

boolean

patients with hcc in whom all possible treatment options have been exhausted.
Descripción

ID.5

Tipo de datos

boolean

Exclusion Criteria
Descripción

Exclusion Criteria

Alias
UMLS CUI
C0680251
patients with hcc who are suitable candidates for established modalities of treatment i.e. surgery and/or chemotherapy.
Descripción

ID.6

Tipo de datos

boolean

patients with hcc who have no evidence of tumor metastasis
Descripción

ID.7

Tipo de datos

boolean

patients with hcc who are willing to take established modalities of treatment i.e. surgery and/or chemotherapy.
Descripción

ID.8

Tipo de datos

boolean

patients with hcc who are voluntarily unwilling to be included in the trial
Descripción

ID.9

Tipo de datos

boolean

Volver a la parte superior de la página

Similar models

Eligibility Hepatocellular Carcinoma NCT01392131

1 formularios
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de datos
Alias
Item Group
C1512693 (UMLS CUI)
ID.1
Item
patients with hcc irrespective of etiology, age, gender and status of underlying liver disease.
boolean
ID.2
Item
patients with hcc who are not suitable candidates for established modalities of treatment i.e. surgery and/or chemotherapy.
boolean
ID.3
Item
patients with hcc who have evidence of tumor metastasis
boolean
ID.4
Item
patients with hcc who are voluntarily unwilling to take established modalities of treatment i.e. surgery and/or chemotherapy.
boolean
ID.5
Item
patients with hcc in whom all possible treatment options have been exhausted.
boolean
Item Group
C0680251 (UMLS CUI)
ID.6
Item
patients with hcc who are suitable candidates for established modalities of treatment i.e. surgery and/or chemotherapy.
boolean
ID.7
Item
patients with hcc who have no evidence of tumor metastasis
boolean
ID.8
Item
patients with hcc who are willing to take established modalities of treatment i.e. surgery and/or chemotherapy.
boolean
ID.9
Item
patients with hcc who are voluntarily unwilling to be included in the trial
boolean
Volver a la parte superior de la página 

Contacto

Utilice este formulario para comentarios, preguntas y sugerencias.

Los campos marcados con * son obligatorios.

Ayuda

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial